Restricted RFP - Call for Nominations

 

Agency:  Colorado Office of Economic Development and International Trade (OEDIT)

 

Bioscience Discovery Evaluation Grant Program

 

Proof of Concept Rules & Application (PDF)

(Click for detailed information)

 

The Bioscience Discovery Evaluation Grant Program (BDEGP or Program), pursuant to C.R.S. 24-48.5-108 and 12-47.1-701, was established by the Colorado legislature to supply needed resources for improving and accelerating the evaluation process for bioscience research discoveries, to determine the best disposition of these discoveries, and to accelerate viable technologies toward commercialization.  The legislature declared that it is in the best interests of the state’s economic growth to dedicate financial resources to facilitate the development of new bioscience research discoveries in Colorado and promote Colorado-based bioscience technologies that will ultimately create new bioscience companies and additional primary jobs in Colorado.

 

The Proof-of-Concept grants under the Bioscience Discovery Evaluation Grant Program (BDEGP) are intended to support bioscience discoveries that will likely lead to the development of new products, services, businesses and employment in the bioscience industry in Colorado. Grants will be accessible to Offices of Technology Transfer (OTT) affiliated with qualified Research Institutions in order to enhance the commercial potential of bioscience research projects that focus on life sciences, engineering, material sciences computer sciences, photonics, or nanotechnology.

 

Eligibility:  Research Institutions located and operating in Colorado that are public or private, nonprofit institutions of higher education, nonprofit teaching hospitals, or private, nonprofit medical and research centers.  For-profit entities are not eligible for the Program.  Applications will be submitted by the (OTT) affiliated with one of the Research Institutions.  All grants are awarded to OTTs at qualified Research Institutions; the OTTs will distribute the grant funds to universities for the specific approved project.

 

Cost Share Requirement:  $1:$1 Minimum.  Allowable matching funds include college/departmental funds, grants/donations from individuals, private industry, foundations, and other specific funds as approved by the state’s OEDIT office on a case-by-case basis and specifically dedicated for use in the proposed bioscience or biofuels research project. 

 

F&A Rate Cap:  8% of the project’s total direct costs.

 

Maximum Budget:  Proof-of-Concept grants are limited to $75,000 each and require a 1:1 match (total project $150,000)

 

The on-campus nomination process:

           

·         All budgets must be submitted and approved by OSP at least five (5) working days prior to the application deadline (September 30, 2009).

·         Submit a full application by e-mail to the CSURF Technology Transfer Office at HB1001@csurf.colostate.edu, by 5pm on September 30, 2009. 

·         All proposers should also submit an invention disclosure(s) relating to new innovations disclosed/proposed within the application.  If there is an existing invention disclosure on file with CSURF, please note the invention reference number.

 

Proposals will be competitively evaluated by a Bioscience Discovery Evaluation Grant Committee (BDEGC).  Applications will be evaluated on the potential for commercial application/success, and on scientific merit.  The potential for the creation of new bioscience companies and additional primary jobs in Colorado is a key interest of the BDEGC, and a consideration by the BDEGC in evaluating applications. 

 

Questions may be directed to any of the following individuals:

 

Carol Clem (carol.clem@colostate.edu)

Terry Opgenorth, COO, NeoTREX (terry.opgenorth@neotrex.org)

Joe Guiles, COO, MicroRx (joe.guiles@colostate.edu)

Todd Headley, CSURF (todd.headley@csurf.colostate.edu)

Jeremy Nelson,CSURF (jeremy.nelson@colostate.edu)

Dian Kammeyer, CSURF (dian.kammeyer@csurf.colostate.edu)

Steve Foster, NeoTREX (steve@neotrex.org)

Rod Tompkins, MicroRx (rod@microrx.org)

Betty Eckert, Associate Director OSP (betty.eckert@colostate.edu)